SE8602743L - Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid - Google Patents

Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid

Info

Publication number
SE8602743L
SE8602743L SE8602743A SE8602743A SE8602743L SE 8602743 L SE8602743 L SE 8602743L SE 8602743 A SE8602743 A SE 8602743A SE 8602743 A SE8602743 A SE 8602743A SE 8602743 L SE8602743 L SE 8602743L
Authority
SE
Sweden
Prior art keywords
gycoside
antitumorantracycling
injection solutions
solutions including
anthracycline glycoside
Prior art date
Application number
SE8602743A
Other languages
English (en)
Other versions
SE466383B (sv
SE8602743D0 (sv
SE466383C (sv
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Ponti Roberto De
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8602743(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE8602743D0 publication Critical patent/SE8602743D0/sv
Publication of SE8602743L publication Critical patent/SE8602743L/sv
Publication of SE466383B publication Critical patent/SE466383B/sv
Publication of SE466383C publication Critical patent/SE466383C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
SE8602743A 1985-08-02 1986-06-19 Injicerbar bruksfärdig antracyklinglykosidlösning samt förfarande för dess framställning SE466383C (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519452A GB8519452D0 (en) 1985-08-02 1985-08-02 Injectable solutions

Publications (4)

Publication Number Publication Date
SE8602743D0 SE8602743D0 (sv) 1986-06-19
SE8602743L true SE8602743L (sv) 1987-02-03
SE466383B SE466383B (sv) 1992-02-10
SE466383C SE466383C (sv) 1996-02-19

Family

ID=10583216

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602743A SE466383C (sv) 1985-08-02 1986-06-19 Injicerbar bruksfärdig antracyklinglykosidlösning samt förfarande för dess framställning

Country Status (34)

Country Link
US (1) US4946831A (sv)
JP (1) JPH0655667B2 (sv)
KR (1) KR920001773B1 (sv)
CN (1) CN1064531C (sv)
AT (1) AT397463B (sv)
BE (1) BE905202A (sv)
BG (1) BG60425B2 (sv)
CA (1) CA1291037C (sv)
CH (2) CH668911C1 (sv)
CS (1) CS277561B6 (sv)
CY (1) CY1592A (sv)
DE (1) DE3621844C2 (sv)
DK (1) DK167557B1 (sv)
ES (1) ES8801580A1 (sv)
FI (1) FI86800C (sv)
FR (1) FR2585569B1 (sv)
GB (2) GB8519452D0 (sv)
GR (1) GR861556B (sv)
HK (1) HK93990A (sv)
HU (1) HU196123B (sv)
IE (1) IE59297B1 (sv)
IL (1) IL79129A (sv)
IT (1) IT1204906B (sv)
NL (2) NL191507C (sv)
NO (1) NO170913C (sv)
NZ (1) NZ216604A (sv)
PH (1) PH22332A (sv)
PT (1) PT82865B (sv)
RU (2) RU1837883C (sv)
SE (1) SE466383C (sv)
SG (1) SG80690G (sv)
UA (1) UA29383C2 (sv)
YU (1) YU44788B (sv)
ZA (1) ZA864792B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
PT86285B (pt) * 1986-12-05 1990-11-07 Erba Farmitalia Processo para a preparacao de solucoes injectaveis contendo um glicosido antraciclinico anti-tumor
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
EP0372889B1 (en) * 1988-12-05 1993-03-24 Bristol-Myers Squibb Company Doxorubicin solutions
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
DE19544532C2 (de) * 1995-11-29 1997-12-11 Pharma Dynamics Gmbh Verfahren zum Herstellen eines Doxorubicin-Lyophilisats
ATE195526T1 (de) * 1996-12-16 2000-09-15 Pharmachemie Bv Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin
EP0954283B1 (en) 1996-12-30 2007-03-21 Battelle Memorial Institute Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation
US20090253220A1 (en) * 2003-10-28 2009-10-08 Sukanta Banerjee Absorbing Biomolecules into Gel-Shell Beads
CA2606390A1 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
US20140378404A1 (en) * 2011-10-25 2014-12-25 Nektar Therapeutics Treatment of Patients Suffering from Cancer
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE2738656A1 (de) * 1977-08-26 1979-03-08 Microbial Chem Res Found Anthracyclinglycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2433027A1 (fr) * 1978-08-08 1980-03-07 Rhone Poulenc Ind Nouveau procede de preparation de derives de la doxorubicine
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
PT86285B (pt) * 1986-12-05 1990-11-07 Erba Farmitalia Processo para a preparacao de solucoes injectaveis contendo um glicosido antraciclinico anti-tumor

Also Published As

Publication number Publication date
RU2110263C1 (ru) 1998-05-10
SG80690G (en) 1990-11-23
PT82865B (pt) 1989-01-17
NL300011I1 (nl) 2000-10-02
CH690490C2 (de) 2000-09-29
BE905202A (fr) 1987-02-02
DK167557B1 (da) 1993-11-22
CH668911C1 (de) 2000-05-31
KR870001828A (ko) 1987-03-28
FI86800C (sv) 1999-10-28
NL191507B (nl) 1995-04-18
NO862587D0 (no) 1986-06-26
CS470886A3 (en) 1992-11-18
IE59297B1 (en) 1994-02-09
FI862629A0 (fi) 1986-06-19
IT1204906B (it) 1989-03-10
NL8601698A (nl) 1987-03-02
GR861556B (en) 1986-10-17
CH668911A5 (de) 1989-02-15
NL191507C (nl) 2000-02-16
BG60425B2 (bg) 1995-03-31
ES8801580A1 (es) 1988-02-16
NZ216604A (en) 1989-10-27
FR2585569B1 (fr) 1990-01-19
ZA864792B (en) 1988-02-24
PH22332A (en) 1988-07-29
FR2585569A1 (fr) 1987-02-06
RU1837883C (ru) 1993-08-30
GB8519452D0 (en) 1985-09-11
IE861598L (en) 1987-02-02
IT8620917A0 (it) 1986-06-26
KR920001773B1 (ko) 1992-03-02
JPS6248629A (ja) 1987-03-03
NO170913C (no) 2003-10-10
SE466383B (sv) 1992-02-10
GB2178311A (en) 1987-02-11
FI862629A (fi) 1987-02-03
NO170913B (no) 1992-09-21
SE8602743D0 (sv) 1986-06-19
AU598197B2 (en) 1990-06-21
AU5885886A (en) 1987-02-12
YU103586A (en) 1988-04-30
DE3621844A1 (de) 1987-03-05
DE3621844C2 (de) 1994-02-17
AT397463B (de) 1994-04-25
FI86800B (fi) 1992-07-15
UA29383C2 (uk) 2000-11-15
JPH0655667B2 (ja) 1994-07-27
HUT42326A (en) 1987-07-28
CN86104283A (zh) 1987-01-28
CN1064531C (zh) 2001-04-18
YU44788B (en) 1991-02-28
CY1592A (en) 1992-04-03
NO862587L (no) 1987-02-03
ES556291A0 (es) 1988-02-16
IL79129A0 (en) 1986-09-30
HK93990A (en) 1990-11-23
DK306286D0 (da) 1986-06-27
SE466383C (sv) 1996-02-19
CS277561B6 (en) 1993-03-17
US4946831A (en) 1990-08-07
CA1291037C (en) 1991-10-22
ATA176886A (de) 1993-09-15
GB8614800D0 (en) 1986-07-23
IL79129A (en) 1992-03-29
GB2178311B (en) 1989-10-11
DK306286A (da) 1987-02-03
HU196123B (en) 1988-10-28
PT82865A (en) 1986-07-01

Similar Documents

Publication Publication Date Title
SE8602743L (sv) Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid
SE8504945D0 (sv) Pharmaceutical compositions containing anthracycline glycosides
DK179286D0 (da) Insulinpraeparat
BR0013065A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ ou ativação aberrante de leucócitos
RU94022479A (ru) Применение антиэстрогенных соединений, а также фармацевтически приемлемых солей и сольватов для уменьшения концентрации глюкозы в крови, фармацевтический препарат
DK47089A (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
KR930700163A (ko) 연조직 종양의 치료 및/또는 진단 방법
DE3752368D1 (de) Doxorubicin enthaltende einspritzbare gebrauchsfertige Lösungen gegen Krebs
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DK225689D0 (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
KR900017599A (ko) 종양 치료용 약학 조성물
KR880011077A (ko) 유효치료 물질로서 사용하기 위한 tert- 부틸아미노-3(페닐-2'-펜옥시)-1-프로판올-2 및 그의 산부가염
BR9805072A (pt) Composição farmacêutica imunoestimulante e seu método de aplicação

Legal Events

Date Code Title Description
NUG Patent has lapsed